Survivin functions as an apoptosis inhibitor and a regulator of cell division in many tumours.
The intracellular localization of survivin in tumours has been suggested as a prognostic …

Although disease management of head and neck squamous cell carcinomas (HNSCC) has
improved significantly, therapy resistance leading to tumor recurrence still counteracts …

Regional chemotherapy was developed in the 1950s and continues to play an integral part
in the development of newer therapies for advanced solid malignancies. Regional therapies …

Background In this study, a combination of recombinant adenoviral p53 (rAd-p53) gene
therapy and intra-arterial delivery of chemotherapeutic agents for treatment of oral …

The objective of this study was to investigate the therapeutic results of arterial injection
therapy via the superficial temporal artery for 134 cases of stages III and IV (M0) oral cavity …

The aim of the study was to investigate the possible impact of comorbidity on survival of
patients undergoing composite resection and microvascular reconstruction for …

Butyrate is a metabolite produced by oral and colonic microorganism. Butyrate has been
shown to reduce colon cancer, whereas its role in oral carcinogenesis is not clear. Butyrate …

Abstract TO REVIEW THE literature on endovascular therapies available to clinicians to aid
in the management of head, neck, and intracranial tumors. Hypervascular tumors of the …

Purpose: To analyze the dose–volume histogram (DVH) of head-and-neck tumors treated
with boron neutron capture therapy (BNCT) and to determine the advantage of the intra …

BACKGROUND AND PURPOSE: Patients with cancer of the oral cavity often present with
advanced tumor stages, distant metastasis, or severe comorbidities, which render radical …